ILMN Stock Recent News

ILMN LATEST HEADLINES

ILMN Stock News Image - seekingalpha.com

mRNA vaccine companies are overhyped post-pandemic, facing scientific, operational, and regulatory headwinds that limit long-term investment appeal. Scientific and business risks, including delivery challenges and limited efficacy for cancer and infectious diseases, make mRNA-focused biotechs unattractive compared to broader biotech opportunities. Investors seeking exposure should consider 'pick-and-shovel' suppliers like Repligen, Illumina, and Twist Biosciences, which offer more stable financial prospects.

seekingalpha.com 2025 Aug 28
ILMN Stock News Image - prismmediawire.com

Seasoned healthcare CFO with senior experience in capital markets and financial operations across private and publicly traded companies to lead BioStem's financial team POMPANO BEACH, FL, August 14, 2025 – PRISM MediaWire – BioStem Technologies, Inc.

prismmediawire.com 2025 Aug 14
ILMN Stock News Image - zacks.com

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Illumina (ILMN). But which of these two stocks offers value investors a better bang for their buck right now?

zacks.com 2025 Aug 14
ILMN Stock News Image - zacks.com

Evaluate Illumina's (ILMN) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

zacks.com 2025 Aug 05
ILMN Stock News Image - seekingalpha.com

Illumina exceeded Q2FY25 expectations and raised FY25 guidance, driven by resilient Chinese operations and strong clinical market growth, especially in oncology. The company is expanding into proteomics with the SomaLogic acquisition and new single-cell CRISPR offerings, aiming for high future revenue growth. Despite ongoing headwinds from China restrictions and US academic funding cuts, Illumina's cost-cutting and divestments have improved profitability and cash flow.

seekingalpha.com 2025 Aug 04
ILMN Stock News Image - fool.com

Illumina (ILMN) Q2 EPS Jumps 9%

fool.com 2025 Aug 01
ILMN Stock News Image - benzinga.com

Illumina, Inc. ILMN reported better-than-expected earnings for the second quarter on Thursday.

benzinga.com 2025 Aug 01
ILMN Stock News Image - seekingalpha.com

Illumina, Inc. (NASDAQ:ILMN ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Ankur Dhingra - Chief Financial Officer Brian Blanchett - VP of Finance & Treasurer and Interim Head of Investor Relations Jacob Thaysen - CEO & Director Conference Call Participants Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Daniel Gregory Brennan - TD Cowen, Research Division David Michael Westenberg - Piper Sandler & Co., Research Division Douglas Anthony Schenkel - Wolfe Research, LLC Eve Burstein - Sanford C. Bernstein & Co., LLC.

seekingalpha.com 2025 Aug 01
ILMN Stock News Image - zacks.com

Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com 2025 Jul 31
ILMN Stock News Image - zacks.com

Illumina (ILMN) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.36 per share a year ago.

zacks.com 2025 Jul 31
10 of 50